Group Medical Visits for Anxiety and Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether group medical visits (GMVs) can assist individuals with anxiety and depression and whether patients find them practical and enjoyable. Participants will either join a virtual group meeting every two weeks for six months or continue with standard follow-up care. It suits adults in Manitoba dealing with anxiety or depression who can join a virtual group setting from a private space. As an unphased trial, this study provides a unique opportunity to explore innovative care methods in a supportive group environment.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Group Medical Visits are safe for patients with depression and anxiety?
Research shows that Group Medical Visits (GMVs) can safely help people with anxiety and depression. In past studies, participants found GMVs to be a supportive environment for discussing mental health with professionals and peers. No serious side effects or problems have been reported from these group sessions.
These sessions resemble regular mental health check-ups but occur in a group setting, making them as safe as typical one-on-one care. Although GMVs are a newer method, they rely on well-accepted practices in mental health care.12345Why are researchers excited about this trial?
Researchers are excited about the trial for group medical visits for anxiety and depression because it explores a unique approach to mental health care. Unlike traditional treatments, which often involve one-on-one therapy or medication, this method leverages the power of group dynamics and peer support to enhance treatment outcomes. The trial also includes virtual outpatient care, offering flexibility and accessibility for participants who may face barriers to in-person visits. This innovative approach could provide a more holistic and accessible way to manage anxiety and depression, potentially leading to improved patient experiences and outcomes.
What evidence suggests that Group Medical Visits are effective for anxiety and depression?
Research has shown that Group Medical Visits (GMVs) might help reduce symptoms of depression and anxiety. In this trial, participants will either receive standard client services by following up with their primary care provider or engage in virtual outpatient care. Studies have found that telehealth, similar to GMVs, works as effectively as in-person care for easing depression symptoms. In another study, virtual treatments led to about a 45% drop in both anxiety and depression symptoms. People also tend to complete virtual programs more often than traditional in-person ones. These findings suggest that GMVs could be a promising way to manage depression and anxiety.678910
Are You a Good Fit for This Trial?
This trial is for adults in Manitoba with primary mental health issues like social anxiety, generalized anxiety, panic disorder, major depressive disorder or persistent depressive disorder. Participants must speak English and commit to a virtual biweekly group for 1.5 hours from a private location with camera access.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enrollment
Participants are enrolled and randomized into intervention or control groups
Treatment
Participants in the intervention group engage in biweekly virtual group medical visits for 6 months
Follow-up
Participants are monitored for satisfaction and symptom severity at months 3 and 6
What Are the Treatments Tested in This Trial?
Interventions
- Group Medical Visits
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor